GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioForce Nanosciences Holdings Inc (OTCPK:BFNH) » Definitions » ROA %

BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) ROA % : -45,600.00% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is BioForce Nanosciences Holdings ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. BioForce Nanosciences Holdings's annualized Net Income for the quarter that ended in Dec. 2023 was $-0.46 Mil. BioForce Nanosciences Holdings's average Total Assets over the quarter that ended in Dec. 2023 was $0.00 Mil. Therefore, BioForce Nanosciences Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was -45,600.00%.

The historical rank and industry rank for BioForce Nanosciences Holdings's ROA % or its related term are showing as below:

BFNH' s ROA % Range Over the Past 10 Years
Min: -320018.18   Med: -205.22   Max: -14.29
Current: -47200

During the past 13 years, BioForce Nanosciences Holdings's highest ROA % was -14.29%. The lowest was -320018.18%. And the median was -205.22%.

BFNH's ROA % is ranked worse than
100% of 1905 companies
in the Consumer Packaged Goods industry
Industry Median: 2.96 vs BFNH: -47200.00

BioForce Nanosciences Holdings ROA % Historical Data

The historical data trend for BioForce Nanosciences Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioForce Nanosciences Holdings ROA % Chart

BioForce Nanosciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.00 -320,018.18 -1,968.63 -8,100.00 -47,200.00

BioForce Nanosciences Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46,000.00 -52,000.00 -45,600.00 -45,600.00 -45,600.00

Competitive Comparison of BioForce Nanosciences Holdings's ROA %

For the Packaged Foods subindustry, BioForce Nanosciences Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioForce Nanosciences Holdings's ROA % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where BioForce Nanosciences Holdings's ROA % falls into.



BioForce Nanosciences Holdings ROA % Calculation

BioForce Nanosciences Holdings's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-0.472/( (0.001+0.001)/ 2 )
=-0.472/0.001
=-47,200.00 %

BioForce Nanosciences Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-0.456/( (0.001+0.001)/ 2 )
=-0.456/0.001
=-45,600.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


BioForce Nanosciences Holdings  (OTCPK:BFNH) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-0.456/0.001
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.456 / 0)*(0 / 0.001)
=Net Margin %*Asset Turnover
=N/A %*0
=-45,600.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


BioForce Nanosciences Holdings ROA % Related Terms

Thank you for viewing the detailed overview of BioForce Nanosciences Holdings's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Business Description

Traded in Other Exchanges
N/A
Address
2020 General Booth Boulevard, Suite 230, Virginia Beach, VA, USA, 23454
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing.
Executives
Richard Kaiser Kaiser director, 10 percent owner, officer: Secretary/Acting CFO 3419 VIRGINIA BEACH BLVD, UNIT 252, VIRGINIA BEACH VA 23452
Merle Ferguson director, 10 percent owner, officer: CEO/President/Treasurer 2020 GENERAL BOOTH BLVD., SUITE 230, VIRGINIA BEACH VA 23454
Susan Donohue 10 percent owner 19001 S. RICHFIELD AVE, #102, GREEN VALLEY AZ 85614
Michael D Dunham director 12000 W PARK PL, EFFECTIVE MANAGEMENT SYSTEMS INC, MILWAUKEE WI 53224
Gregory D Brown officer: Chief Financial Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010-8098
Kerry M Frey officer: Chief Operating Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010
Eric Henderson director, 10 percent owner BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Lawrence Marshall Gold director 830 MENLO AVENUE, SUITE 100, MENLO PARK CA 94025
Jean-jacques Sunier director BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Societe Generale Asset Management Alternative Investments 10 percent owner 170, PLACE HENRI REGNAULT, LADEFENSE, PARIS I0 92043
Ed Cowle 10 percent owner 6 EAST 45TH ST., SUITE 1000, NEW YORK NY 10017
H Deworth Williams 10 percent owner 2681 EAST PARLEYS WAY, SUITE #204, SALT LAKE CITY UT 84109
Carter Robert P Iii 10 percent owner 25 RADCLIFFE DRIVE, VOORHEES NJ 08043
Harvey N Kaye 10 percent owner 190 NW SPANISH RIVER BLVD., SUITE 101, BOCA RATON FL 33431

BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Headlines

No Headlines